IMTPPE
IMTPPE is an inhibitor of the androgen receptor (AR) in C4-2 prostate cancer cells, inhibiting its transcriptional activity and protein levels. IMTPPE inhibited the proliferation of AR-positive prostate cancer cells but had no effect on AR-negative prostate cancer cells. IMTPPE also inhibited the growth of enzalutamide-resistant 22Rv1 xenograft tumors[1].
Product Specifications
CAS Number
851688-13-6
UNSPSC
12352005
Target
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/imtppe.html
Smiles
O=C(CSCC1=C(ON=C1C)C)N2CCN(CC2)C3=CC=CC(C)=C3C
Molecular Formula
C20H27N3O2S
Molecular Weight
373.51
References & Citations
[1]Inhibition of androgen receptor function and level in castration-resistant prostate cancer cells by 2- ((isoxazol-4-ylmethyl) thio) -1- (4-phenylpiperazin-1- yl) ethanone
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15393630 1 Vial
Lentiviral human RNLS sgRNA gene knockout kit - Lentiviral human RNLS sgRNA gene knockout kit (25)
Sign In for Pricing
View Details MBS2123132-01 0.01 mg
Recombinant Phosphatidic Acid Phosphatase Type 2C (PPAP2C)
Sign In for Pricing
View Details MBS2123132-02 0.05 mg
Recombinant Phosphatidic Acid Phosphatase Type 2C (PPAP2C)
Sign In for Pricing
View Details MBS2123132-03 0.1 mg
Recombinant Phosphatidic Acid Phosphatase Type 2C (PPAP2C)
Sign In for Pricing
View Details MBS2123132-04 0.2 mg
Recombinant Phosphatidic Acid Phosphatase Type 2C (PPAP2C)
Sign In for Pricing
View Details